A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients WHO had GH deficiency during childhood

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 8, 2001, Pages 3494-3498

  Wiren L ^a   Johannsson, G ^a   Bengtsson, B A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; PERSONALITY TEST; PRIORITY JOURNAL; QUALITY OF LIFE; WELLBEING;

ADOLESCENT; ADULT; AFFECT; ANALYSIS OF VARIANCE; COGNITION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMAN GROWTH HORMONE; HUMANS; MALE; MENTAL STATUS SCHEDULE; PITUITARY DISEASES; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; TIME FACTORS;

EID: 0034886797     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.8.3494     Document Type: Article

References (43)

1. Quality of life of adults with growth hormone deficiency: A controlled study
2. Decreased psychological well-being in adult patients with growth hormone deficiency
3. One-year follow-up of quality of life in adults with untreated growth hormone deficiency
4. GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety
5. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status
6. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: Validation of the measure by rasch analysis
7. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency
8. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
9. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled clinical trials
10. Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial
11. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
12. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults
13. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency
14. Influences on quality of life in GH deficient adults and their effect on response to treatment
15. Quality of life, body composition and muscle strength in adult growth hormone deficiency; the influence of growth hormone replacement therapy for up to 3 years
16. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency
17. Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: A randomised crossover trial
18. Quality of life among formerly treated childhood-onset growth hormone-deficient adults: A comparison with unaffected siblings
19. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
20. The educational, vocational and marital status of growth hormone-deficient adults treated with growth hormone during childhood
21. Psychosocial impact of long-term growth hormone therapy
22. Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature
23. Evidence for social phobia and other psychiatric disorders in adults who were growth hormone deficient during childhood
24. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
25. Growth hormone therapy and fracture risk in the growth hormone-deficient adult
26. Changes in skeletal muscle and body composition after discontinuing of growth hormone treatment in growth hormone deficient adults
27. Discontinuation of growth hormone (GH) treatment: Metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
28. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
29. Consequences of childhood-onset growth hormone deficiency of adult bone mass
30. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency
31. A quantitative approach to perceived health status: A validation study
32. The psychological general well-being (PGWB) index
33. The measurements of mood
34. Mood and somatic symptoms
35. A new self-assessment questionnaire to measure well-being in children
36. Validity of the Trail Making Tests as an indication of organic brain damage
37. The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency
38. Cognitive impairments and mood disturbances in growth hormone deficient men
39. The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease